Different cytokines modulate ubiquitin gene expression in rat skeletal muscle

Cancer Letters

Volumn 133, Issue 1, 1998, Pages 83-87

  Llovera, Marta ^a   Carbó, Neus ^a   López Soriano, Joaquín ^a   García Martínez, Cèlia ^a   Busquets, Sílvia ^a   Alvarez, Belén ^a   Agell, Neus ^a   Costelli, Paola ^b   López Soriano, Francisco J ^a   Celada, Antonio ^a   Argilés, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cancer cachexia; IFN ; IL 1; IL 6; LIF; Muscle waste; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; CACHEXIA; CYTOKINES; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINS;

EID: 0032416035     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00216-X     Document Type: Article

References (36)

1. Evans R.D., Argilés J.M., Williamson D.H. Metabolic effects of tumour necrosis factor-α (cachectin) and interleukin-1. Clin. Sci. 77:1989;357-364.
2. Argilés J.M., López-Soriano F.J., Wiggins D., Williamson D.H. Comparative effects of tumour necrosis factor-α (cachectin), interleukin-1-β and tumour growth on amino acid metabolism in the rat in vivo. Biochem. J. 261:1989;357-362.
3. Argilés J.M., García-Martínez C., Llovera M., López-Soriano F.J. The role of cytokines in muscle wasting: its relation with cancer cachexia. Med. Res. Rev. 12:1992;637-652.
4. Costelli P., Carbó N., Tessitore L., Bagby G.J., López-Soriano F.J., Argilés J.M., Baccino F.M. Tumour necrosis factor-α mediates changes in muscle protein turnover in a cachectic rat tumour model. J. Clin. Invest. 92:1993;2783-2789.
5. Llovera M., López-Soriano F.J., Argilés J.M. Effects of tumour necrosis factor-α on muscle protein turnover in vivo in female Wistar rats. J. Natl. Cancer Inst. 85:1993;1334-1339.
6. Llovera M., López-Soriano F.J., Argilés J.M. Chronic tumour necrosis factor-α treatment modifies protein turnover in rat tissues. Biochem. Mol. Biol. Int. 30:1993;29-36.
7. Llovera M., García-Martínez C., Agell N., Marzábal M., López-Soriano F.J., Argilés J.M. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett. 338:1994;311-318.
8. Llovera M., García-Martínez C., Agell N., López-Soriano F.J., Argilés J.M. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int. J. Cancer. 61:1995;138-141.
9. García-Martínez C., Agell N., Llovera M., López-Soriano F.J., Argilés J.M. Tumour necrosis factor-α increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett. 323:1993;211-214.
10. García-Martínez C., López-Soriano F.J., Argilés J.M. Acute treatment with tumour necrosis factor-α induces changes in protein metabolism in rat skeletal muscle. Mol. Cell. Biochem. 125:1993;11-18.
11. García-Martínez C., Llovera M., Agell N., López-Soriano F.J., Argilés J.M. Ubiquitin gene expression in skeletal muscle is increased by tumour necrosis factor-α Biochem. Biophys. Res. Commun. 201:1994;682-686.
12. Llovera M., Carbó N., García-Martínez C., Costelli P., Tessitore L., Baccino F.M., Agell N., Bagby G.J., López-Soriano F.J., Argilés J.M. Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. Biochem. Biophys. Res. Commun. 221:1996;653-655.
13. Strassmann G., Fong M., Freter C.E., Windsor S., D'Alessandro F., Nordan R.P. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo. J. Clin. Invest. 92:1993;2152-2159.
14. Goodman M.N. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc. Soc. Exp. Biol. Med. 205:1994;182-185.
15. Fong Y., Moldawer L.L., Morano M., Wei H., Barber A., Manogue K., Tracey K.J., Kuo G., Fischman D.A., Cerami A., Lowry S.F. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am. J. Physiol. 256:1989;R659-R665.
16. Matthys P., Heremans H., Opdenakker G., Billiau A. Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. Eur. J. Cancer. 27:1991;182-187.
17. Matthys P., Dukmans R., Proost P., Van Damme J., Heremans H., Sobis H., Billiau A. Severe cachexia in mice inoculated with interferon-γ-producing tumor cells. Int. J. Cancer. 49:1991;77-82.
18. Mori M., Yamaguchi K., Honda S., Nagasaki K., Ueda M., Abe O., Abe K. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitor factor. Cancer Res. 51:1991;6656-6659.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
20. Bond U., Schlesinger M.J. Ubiquitin is a heat-shock protein in chicken embryo fibroblasts. Mol. Cell. Biol. 5:1985;949-956.
21. Grunfeld C., Feingold K.R. Tumor necrosis factor, interleukin and interferon induced changes in lipid metabolism as part of host defense. Proc. Soc. Exp. Biol. Med. 200:1992;224-227.
22. Warren R.S., Starnes H.F. Jr., Gabrilove J.L., Oettgen H.F., Brennan M.F. The acute metabolic effects of tumor necrosis factor administration to humans. Arch. Surg. 122:1987;1396-1400.
23. Flores E.A., Bistrian B.R., Pomposelli J.J., Dinarello C.A., Blackburn G.L., Istfan N.W. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in rats. J. Clin. Invest. 83:1989;1614-1622.
24. Goodman M.N. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am. J. Physiol. 260:1991;E727-E730.
25. Hershko A., Ciechanover A., Heller H., Haas A.L., Rose I.A. Proposed role of ATP in protein breakdown: conjugation of proteins with multiple chains of polypeptide of ATP-dependent proteolysis. Proc. Natl. Acad. Sci. USA. 77:1980;1783-1786.
26. Ciechanover A., Finley D., Varshavsky A. The ubiquitin-dependent pathway and mechanisms of energy-dependent intracellular protein degradation. J. Cell. Biochem. 24:1984;27-53.
27. Finley D., Varshavsky A. The ubiquitin system: functions and mechanisms. Trends Biochem. Sci. 10:1985;343-347.
28. Finley D., Chan V. Ubiquitination. Annu. Rev. Cell Biol. 7:1991;25-69.
29. Rechsteiner M. Natural substrates of the ubiquitin proteolytic pathway. Cell. 66:1991;615-618.
30. Peters J.M. Proteasomes: protein degradation machines of the cell. Trends Biochem. Sci. 19:1994;377-382.
31. Hilenski L.L., Terracio L., Haas A.L., Borg T.K. Immunolocalization of ubiquitin conjugates at Z-bands and intercalates discs of rat cardiomyocytes in vitro and in vivo. J. Histochem. Cytochem. 40:1992;1037-1042.
32. Soda K., Kawakami M., Kashii A., Miyata M. Characterization of mice bearing subclones of colon 26 adenocarcinoma disqualifies interleukin-6 as the sole inducer of cachexia. Jpn. J. Cancer Res. 85:1994;1124-1130.
33. Soda K., Kawakami M., Kashii A., Miyata M. Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6. Int. J. Cancer. 62:1995;332-336.
34. García-Martínez C., López-Soriano F.J., Argilés J.M. Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Lett. 76:1994;1-4.
35. Patton J.S., Shepard H.M., Wilking H., Lewis G., Aggarwal B.B., Eessalu T.E., Gavin L.A., Grunfeld C. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc. Natl. Acad. Sci. USA. 83:1986;8313-8317.
36. Zugmaier G., Paik S., Wilding G., Knabbe K., Bano M., Lupu R., Deschauer B., Simpson S., Dickson R.B., Lippman M. Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res. 51:1991;3590-3594.